Stratos Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$419K Sell
6,677
-592
-8% -$47.4K 0.03% 421
2025
Q4
$693K Sell
7,269
-887
-11% -$87K 0.03% 372
2025
Q3
$796K Buy
8,156
+998
+14% +$103K 0.04% 363
2025
Q2
$769K Buy
7,158
+778
+12% +$78.7K 0.04% 357
2025
Q1
$644K Sell
6,380
-189
-3% -$19K 0.04% 385
2024
Q4
$587K Buy
6,569
+150
+2% +$13.2K 0.03% 431
2024
Q3
$538K Buy
6,419
+522
+9% +$41.1K 0.02% 484
2024
Q2
$454K Buy
5,897
+2,341
+66% +$171K 0.02% 495
2024
Q1
$244K Sell
3,556
-2,052
-37% -$132K 0.01% 589
2023
Q4
$324K Buy
5,608
+833
+17% +$44.5K 0.02% 538
2023
Q3
$252K Buy
+4,775
New +$250K 0.02% 573

Other funds holding BSX

Stratos Wealth Advisors's BSX Position: Q1 2026 in Review

Stratos Wealth Advisors reduced its Boston Scientific (BSX) stake by 8.1% in Q1 2026, selling an estimated $47.4K and leaving 6,677 shares worth $419K. The position accounts for 0.03% of the portfolio, ranked #421.

Stratos Wealth Advisors first reported a position in BSX in Q3 2023 and has held it in 11 quarters since. The position peaked at $796K in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Stratos Wealth Advisors held 6,677 shares of Boston Scientific worth $419K as of Q1 2026.
  • Stratos Wealth Advisors sold 592 Boston Scientific shares in Q1 2026, an estimated $47.4K.
  • Boston Scientific made up 0.03% of Stratos Wealth Advisors's portfolio in Q1 2026, its #421 holding.
  • Stratos Wealth Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 11 quarters since.
  • Stratos Wealth Advisors's Boston Scientific position peaked at $796K in Q3 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.